These results suggest that paeoniflorin reverse HGF-mediated migration, invasion, and actin cytoskeleton rearrangement by targeting c-Met and RhoA/ROCK pathway in glioblastoma cells. The gene discussed is RHOA; the disease is glioblastoma.